Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders…
$72.94-1.04%
报价 2026-11-13
市值
$7.98B
EV
$12.15B
PE (TTM)
218.0x
预期 PE (FY2026)
32.2x
52 周区间距高点 -41.0%
$32.15$123.57
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
爆发潜力
2026-11-13不在筛选范围:industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| CORTCorcept Therapeutics Incorporated | $7.98B | -1.0% | +41.9% | 98.3% | 218.0x | 422.2x | 114.6x | |
| JAZZJazz Pharmaceuticals plc | $15.5B | +0.5% | – | 88.2% | – | 109.6x | – | |
| HALOHalozyme Therapeutics, Inc. | $11.43B | -0.4% | +36.3% | 78.2% | 29.3x | 20.9x | 15.2x | |
| RYTMRhythm Pharmaceuticals, Inc. | $7.97B | +4.7% | +75.7% | 88.2% | – | – | – | |
| CYTKCytokinetics, Incorporated | $7.82B | -0.1% | +110.5% | -22.3% | – | – | – | |
| ABVXAbivax S.A. | $7.67B | -2.9% | – | 0% | – | – | – | |
| AXSMAxsome Therapeutics, Inc. | $7.45B | -1.9% | +50.1% | 92.6% | – | – | – | |
| CAICaris Life Sciences, Inc. | $6.61B | -3.8% | +37.6% | 69.7% | 80.6x | 47.7x | 57.9x | |
| RNAAvidity Biosciences, Inc. | $162M | +0.1% | -61.9% | 100% | – | – | – | |
| 同行中位数 | – | – | +43.8% | 83.2% | 55.0x | 47.7x | 36.5x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据(首次研究运行后填充)。